SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Boston Scientific (BSX) Any Comments???
BSX 100.55+0.2%Oct 30 3:59 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: OldAIMGuy who wrote (788)7/31/2002 4:19:13 PM
From: Lighthouse  Read Replies (1) of 798
 
No comments on yesterday's GDT announcement? This certainly takes some of the upside away from BSX in the 03 and 04 time periods. As GDT said nothing is certain; however, the license to paclitaxel technology now looks like it will be within GDT's hand.

I have to scale back some market share percentages for BSX in those years and also take away the possibility of hefty royalty payments from GDT to BSX. BSX will still be a major player in this new field and that will help immensely. Both revenues and margins should rise in 03 and 04 for BSX.

Just not the knockout punch they almost had garnered.

Cheers,
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext